Contact this trialFirst, we need to learn more about you.
Hedgehog Pathway Inhibitor
Glasdegib for Graft-versus-Host Disease
Recruiting1 awardPhase 1 & 2
Salt Lake City, Utah
This trial will study whether glasdegib is helpful in treating sclerosis associated with chronic graft-versus-host disease, as well as the safety of glasdegib in treating patients with chronic graft-versus-host disease.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.